Hirsutism and Quality of Life

    January 2010 in “ Springer eBooks
    Shân Davies
    Image of study
    TLDR Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.
    The document from 2010 examines the psychological and social effects of hirsutism on women, noting that it can cause stress, anxiety, and depression, and negatively impact employment opportunities. It affects 5-8% of women and can result in significant time and money spent on hair removal. Treatment options, such as eflornithine cream and mechanical hair removal, have limited effectiveness and potential side effects. Despite this, women and their partners are willing to pay for effective treatments, with eflornithine cream offering a small gain in Quality Adjusted Life Years (QALYs) and being cost-effective. The document calls for more research into treatments and sensitive clinical care for women with hirsutism.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 25 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 4 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 3 months ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  119 upvotes 5 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  11 upvotes 1 year ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Similar Research

    5 / 1000+ results
      Androgen Excess: Investigations and Management

      research Androgen Excess: Investigations and Management

      82 citations, May 2016 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”
      The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.
      Pseudofolliculitis Barbae: Current Treatment Options

      research Pseudofolliculitis Barbae: Current Treatment Options

      21 citations, April 2019 in “Clinical, cosmetic and investigational dermatology”
      The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).
      The Evaluation and Management of Hirsutism

      research The Evaluation and Management of Hirsutism

      195 citations, May 2003 in “Obstetrics and gynecology (New York. 1953. Online)/Obstetrics and gynecology”
      Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.